Our Portfolio 

Our portfolio reflects the scale and diversity of the broader healthcare venture capital market.

 

For over 13 years, we have created customized solutions for venture funds, corporate venture funds, limited partnership interests, operating companies, and individual shareholders.

download.jpg

Labcyte Inc. is a laboratory instrumentation company with a novel approach to dispensing small volumes of liquids for life sciences applications. It was acquired by Beckman Coulter Life Sciences in 2019.

Adaptive Biotechnologies is a leader in immune-driven medicine. IPO in 2019, NASDAQ: ADPT.

Crescendo Bioscience develops diagnostic tools for rheumatologists to manage patients with autoimmune and inflammatory diseases. It was acquired by Myriad Genetics in 2014.

Counsyl_Logo_highres.jpg

Counsyl is a health technology company that offers DNA screening for men, women, and their children. It was acquired by Myriad Genetics in 2018.